Cyclic PSAP peptide

Unveiling an unrivaled breakthrough, Cyclic PSAP Peptide emerges as an exceedingly powerful therapeutic asset in the realm of Alzheimer's disease treatment. Its ingenious mechanism primarily revolves around honing in on the perplexing accumulation of beta-amyloid plaques within the enigmatic confines of the brain, an emblematic characteristic emblematic of this pernicious ailment. With unparalleled efficacy, this groundbreaking peptide systematically curtails the onerous burden of these plaques, ushering in a transformative era of enhanced cognitive functionality, potentially impeding the relentless progression of Alzheimer's.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	GR2175
CAS	1443985-29-2
Chemical Name	(2S)-6-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid
M.F/Formula	C32H47N7O8
M.W/Mr.	657.76

CAT#	Product Name	Inquiry
GR2194	GPLGIAGQ TFA	Inquiry
GR2128	P22 N-(14-30)	Inquiry
GR2117	TfR Targeting Peptide	Inquiry
GR2172	hCT(18-32)	Inquiry
GR2187	HAIYPRH hydrochloride	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
InChI	InChI=1S/C32H47N7O8/c1-18(2)14-25(31(45)39-13-7-11-26(39)30(44)36-23(32(46)47)10-5-6-12-33)38-29(43)24(37-28(42)21(34)16-27(40)41)15-19-17-35-22-9-4-3-8-20(19)22/h3-4,8-9,17-18,21,23-26,35H,5-7,10-16,33-34H2,1-2H3,(H,36,44)(H,37,42)(H,38,43)(H,40,41)(H,46,47)/t21-,23-,24-,25-,26-/m0/s1
InChI Key	LVXGIUZDWZWJNU-GKKOWRRISA-N
Canonical SMILES	CC(C)CC(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC(=O)O)N
Isomeric SMILES	CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC(=O)O)N